Fox Chase Cancer Center’s Dr. Allision Aggon Receives Earth Angel Award From Breast Cancer Nonprofit Organization
Allison A. Aggon, DO, FACOS, of Fox Chase Cancer Center, was recently presented with an Earth Angel Award.
Allison A. Aggon, DO, FACOS, of Fox Chase Cancer Center, was recently presented with an Earth Angel Award.
This fall, and all year long, we encourage you to focus on safety by protecting the delicate skin around your eyes from skin cancer and premature…
The addition of daratumumab to maintenance lenalidomide extended PFS for patients who underwent stem cell transplant for newly diagnosed multiple myeloma, according to study results.The…
PURPOSEThe use of inotuzumab ozogamicin (InO), a conjugated anti-CD22 monoclonal antibody, is becoming a promising frontline treatment for older patients with ALL.PATIENTS AND METHODSEWALL-INO is…
On October 23, 2024, the U.S. Food and Drug Administration (FDA) granted fast track designation to HC-7366, a GCN2-targeting agent, for the treatment of patients…
Steven Treon, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses the unmet needs in treating Waldenström’s macroglobulinemia (WM), particularly in managing high-risk patients and optimizing…
Global Scholar-in-Training Awards are offered to eligible early-career investigators in designated developing countries, who wish to participate in the AACR Annual Meeting.
Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer
SSO supports cancer research by providing research funding through its competitive Clinical Investigator and Young Investigator Awards programs. The SSO Clinical Investigator Award supports patient-focused…
Dr. Leticia Nogueira and other experts explored non-tobacco factors that are playing a role in our evolving knowledge during a WCLC 24 plenary session.
This Viewpoint explores whether the Inflation Reduction Act’s provisions and price negotiations could affect investment in trials of new oncology therapies or indications.